A review on salivary biomarkers in carcinoma diagnosis
1 Department of Medical Biochemistry, NIMS University, Jaipur, Rajasthan, India.
2 Department of Oral Pathology, Government Dental College, Jaipur, Rajasthan, India.
3 Department of Pharmaceutics, Buddha Institute of Pharmacy, GIDA, Gorakhpur, Uttar Pradesh, India.
4 Med. Pharmacology, Department of Pharmacology, National Institute of Medical Sciences & Research, NIMS University, Jaipur, Rajasthan, India.
5 National Institute of Medical Sciences & Research, NIMS University, Jaipur, Rajasthan, India.
Review
Open Access Research Journal of Multidisciplinary Studies, 2021, 01(01), 013–021.
Article DOI: 10.53022/oarjms.2021.1.1.0016
Publication history:
Received on 12 March 2021; revised on 17 April 2021; accepted on 19 April 2021
Abstract:
Carcinoma is the 2nd leading mortality in the U.S. Signs & symptoms include typically unspecific until the tumours metastasize. Hence, an urgency is there for quick, precise, and non-invasive carcinoma diagnosis, rapid detection, diagnosis, stage surveys, & forecasts. Saliva is a multi-structural fluid, found in the oral region, containing secretions from primary and minor salivary glands. Species can even be found in blood-present molecules including Deoxyribo Nucleic Acids, RNAs, hormones, metabolites, and microbiota. Recently, saliva testing received considerable interest in identifying specific biomarkers as sample collection and processing is quick, cost-effective, accurate and doesn’t put any distress on the patient. We examine recent salivary biomarkers of systemic carcinoma by separating them into genomically, transcriptomically, proteomically, metabolomic and microbially dependent forms.
Keywords:
Carcinoma, Deoxyribo Nucleic Acids, RNAs, hormones, metabolites, and microbiota
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0